Find Your Funding Opportunity

Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes
Bookmarked grants will display in your Account Setting page

Service Source Final Application Due Date Funding Available Match Required
Health Care Federal
HHS
10-13-2025 N/A No Match
Required
  • Service
  • Source
  • Final Application Due Date
  • Funding Available
  • Match Required
Status
  • Past
  • Current
  • Forecasted
    • Opportunity Type Discretionary
    • CFDA

      93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research

    Description

    NIDDK intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on the application of digital health technology to the management of type 2 diabetes.The increasing availability of FDA-cleared digital health technology (DHT) for type 2 diabetes (T2D) management holds great promise for addressing current barriers to care. DHT has the capacity to improve access to the health care system, promote and enhance patient engagement and sense of empowerment, improve glycemia and other metabolic outcomes, reduce clinical inertial and provider dissatisfaction, and provide favorable economics at the HCS level. Despite the promise of DHT applications in diabetes and prediabetes management, a rigorous evidenced-based foundation, particularly for multimodality digital health interventions, is lacking. For this NOFO, DHT includes but is not limited to continuous glucose monitoring (CGM), telemedicine with virtual coaching, connected digital devices (e.g., smartwatches, activity monitors, digital scales), mobile health (mHealth) applications for monitoring clinically relevant parameters such dietary intake, medication adherence, mood, behavior, and methods to facilitate bidirectional information exchange with the health care team, including directed text messaging and patient portals. The application of digital interventions utilizing peer support mechanisms to improve diabetes care also are applicable to this NOFO. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.This NOFO will utilize the R01 (Clinical Trial Required) activity code. Investigators with expertise and insights into this area of the application of digital health technology to the management of type 2 diabetes are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in digital health technology will be encouraged and these investigators should also begin considering applying for this application.

    Eligibility
    • IHE
    • Local Government
    • Non-Profit
    • Other
    • State Government
    • Tribal Government
    Additional Eligibility Information

    U.S. Territory or Possession

    Key Date(s)
    • June 05, 2025: Last Updated Date
    • June 05, 2025: Forecasted Date
    • September 12, 2025: Estimated Post Date
    • October 13, 2025: Estimated Application Due Date
    • July 01, 2026: Estimated Award Date
    • August 01, 2026: Estimated Project Start Date
    Contact Information
    Henry B. Burch, M.D. National Institute of Diabetes and Digestive and Kidney Diseases 301-827-0827 henry.burch@nih.gov

    DROP US A LINE

    Feedback Feedback

    Your opinion is important to us

    • How would you rate your overall experience on our website?

    • How easy is it to find the information you need?

    • How do you rate the look & feel of our website?

    • How could we improve our website?